172 related articles for article (PubMed ID: 27230280)
1. Epithelial-mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy.
Rojas-Puentes L; Cardona AF; Carranza H; Vargas C; Jaramillo LF; Zea D; Cetina L; Wills B; Ruiz-Garcia E; Arrieta O
Cancer Med; 2016 Aug; 5(8):1989-99. PubMed ID: 27230280
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
[TBL] [Abstract][Full Text] [Related]
3. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients.
Kamal IM; Temerik DF; Yassin EH; Mosad E; A H; Hussien MT
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4213-4225. PubMed ID: 36580004
[TBL] [Abstract][Full Text] [Related]
5. Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma.
Li Y; Wang W; Wang W; Yang R; Wang T; Su T; Weng D; Tao T; Li W; Ma D; Wang S
Gynecol Oncol; 2012 Jan; 124(1):112-8. PubMed ID: 22018873
[TBL] [Abstract][Full Text] [Related]
6. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
Randall LM; Monk BJ; Darcy KM; Tian C; Burger RA; Liao SY; Peters WA; Stock RJ; Fruehauf JP
Gynecol Oncol; 2009 Mar; 112(3):583-9. PubMed ID: 19110305
[TBL] [Abstract][Full Text] [Related]
7. Locally advanced cervical cancer - neoadjuvant chemotherapy followed by concurrent chemoradiation and targeted therapy as maintenance: A phase II study.
Benson R; Pathy S; Kumar L; Mathur S; Dadhwal V; Mohanti BK
J Cancer Res Ther; 2019; 15(6):1359-1364. PubMed ID: 31898673
[TBL] [Abstract][Full Text] [Related]
8. The indicative function of Twist2 and E-cadherin in HPV oncogene-induced epithelial-mesenchymal transition of cervical cancer cells.
Liu Y; Qian W; Zhang J; Dong Y; Shi C; Liu Z; Wu S
Oncol Rep; 2015 Feb; 33(2):639-50. PubMed ID: 25420506
[TBL] [Abstract][Full Text] [Related]
9. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
Zhang YQ; Wei XL; Liang YK; Chen WL; Zhang F; Bai JW; Qiu SQ; Du CW; Huang WH; Zhang GJ
PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469
[TBL] [Abstract][Full Text] [Related]
10. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer.
Choi CH; Chung JY; Kang JH; Paik ES; Lee YY; Park W; Byeon SJ; Chung EJ; Kim BG; Hewitt SM; Bae DS
Gynecol Oncol; 2020 May; 157(2):437-443. PubMed ID: 32107047
[TBL] [Abstract][Full Text] [Related]
12. MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial.
Kang HB; Kim SH; Lee JH; Lee HC; Kang NK; Lee JH
Int J Clin Oncol; 2024 May; 29(5):620-628. PubMed ID: 38530569
[TBL] [Abstract][Full Text] [Related]
13. Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery.
Zannoni GF; Petrillo M; Vellone VG; Martinelli E; Chiarello G; Ferrandina G; Scambia G
Hum Pathol; 2014 Sep; 45(9):1872-8. PubMed ID: 24997647
[TBL] [Abstract][Full Text] [Related]
14. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of homeobox B-13 correlates with angiogenesis, aberrant expression of EMT markers, aggressive characteristics and poor prognosis in pancreatic carcinoma.
Zhai LL; Wu Y; Cai CY; Tang ZG
Int J Clin Exp Pathol; 2015; 8(6):6919-27. PubMed ID: 26261579
[TBL] [Abstract][Full Text] [Related]
16. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
[TBL] [Abstract][Full Text] [Related]
17. Effects of forkhead Box protein A1 on cell proliferation regulating and EMT of cervical carcinoma.
Gu F; Li ZH; Wang CQ; Yuan QF; Yan ZM
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7189-7196. PubMed ID: 30468461
[TBL] [Abstract][Full Text] [Related]
18. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition.
Liu M; Liu J; Yang B; Gao X; Gao LL; Kong QY; Zhang P; Li H
Anat Rec (Hoboken); 2017 Dec; 300(12):2184-2191. PubMed ID: 28921916
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of annexin A2 and cancer-associated fibroblasts in advanced non-small cell lung cancer: Implication in epithelial-mesenchymal transition and gefitinib resistance.
Ibrahim FM; Helal DS; Ali DA; Abd-Ellatif RN; Elkady AM; Sharshar R; Gharib F; Abo Elnasr M; El-Guindy DM
Pathol Res Pract; 2023 Jan; 241():154293. PubMed ID: 36586309
[TBL] [Abstract][Full Text] [Related]
20. Definitive concurrent chemoradiotherapy in cervical cancer--a University of Malaya Medical Centre experience.
Zamaniah WI; Mastura MY; Phua CE; Adlinda A; Marniza S; Rozita AM
Asian Pac J Cancer Prev; 2014; 15(20):8987-92. PubMed ID: 25374241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
